II 

113TH CONGRESS 

2D SESSION S. 2839 

To authorize the Attorney General to award grants to address the national 

epidemics of prescription opioid abuse and heroin use. 

IN THE SENATE OF THE UNITED STATES 

SEPTEMBER 17 (legislative day, SEPTEMBER 16), 2014 

Mr. WHITEHOUSE (for himself, Mr. PORTMAN, Ms. KLOBUCHAR, Ms. 

AYOTTE, and Mr. LEAHY) introduced the following bill; which was read 

twice and referred to the Committee on the Judiciary 

A BILL 

To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse 

and heroin use. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Comprehensive Addiction and Recovery Act of 2014’’. 

6 (b) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows: 

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

Sec. 3. Definitions. 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•S 2839 IS

TITLE I—PREVENTION AND EDUCATION 

Sec. 101. Development of best prescribing practices. 

Sec. 102. National education campaign. 

Sec. 103. Community-based coalition enhancement grants to address local drug 

crises. 

TITLE II—LAW ENFORCEMENT AND TREATMENT 

Sec. 201. Treatment alternative to incarceration programs. 

Sec. 202. Law enforcement naloxone training and implementation pilot. 

Sec. 203. Prescription drug take back expansion. 

TITLE III—TREATMENT AND RECOVERY 

Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration. 

Sec. 302. Criminal justice medication assisted treatment and interventions demonstration. 

Sec. 303. National youth recovery initiative. 

Sec. 304. Building communities of recovery. 

TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 

Sec. 401. Correctional education demonstration grant program. 

Sec. 402. Revision of FAFSA form. 

Sec. 403. National Task Force on Recovery and Collateral Consequences. 

TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 

FAMILIES, AND VETERANS 

Sec. 501. Authority to award competitive grants to address opioid and heroin 

abuse by pregnant and parenting female offenders. 

Sec. 502. Grants for family-based substance abuse treatment. 

Sec. 503. Veterans’ treatment courts. 

TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES 

TO ADDRESS OPIOID AND HEROIN ABUSE 

Sec. 601. State demonstration grants for comprehensive opioid abuse response. 

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) The abuse of heroin and prescription pain4 killers is having a devastating effect on public health 

5 and safety in communities across the United States. 

6 According to the Centers for Disease Control and 

7 Prevention, drug overdose deaths now surpass traffic 

8 crashes in the number of deaths caused by injury in 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•S 2839 IS

1 the United States. In 2011, an average of about 110 

2 people in the United States died from drug overdose 

3 every day. 

4 (2) Law enforcement officials and treatment ex5 perts throughout the country report that many pre6 scription opioid users have turned to heroin as a 

7 cheaper or more easily obtained alternative to pre8 scription drugs. 

9 (3) Opioid pain relievers are the most widely 

10 misused or abused controlled prescription drugs 

11 (commonly referred to as ‘‘CPDs’’) and are involved 

12 in most CPD-related overdose incidents. According 

13 to the Drug Abuse Warning Network (commonly 

14 known as ‘‘DAWN’’), the estimated number of emer15 gency department visits involving nonmedical use of 

16 prescription opiates or opioids increased by 112 per17 cent, from 84,671 to 179,787, between 2006 and 

18 2010. 

19 (4) According to a report by the National Asso20 ciation of State Alcohol and Drug Abuse Directors 

21 (commonly referred to as ‘‘NASADAD’’), 37 States 

22 reported an increase in admissions to treatment for 

23 heroin use during the past 2 years, while admissions 

24 to treatment for prescription opiates increased 500 

25 percent from 2000 to 2012. 


emcdonald on DSK67QTVN1PROD with BILLS
4 

•S 2839 IS

1 (5) Addiction is a treatable disease. Discoveries 

2 in the science of addiction have led to advances in 

3 the treatment of substance use disorders that help 

4 people stop abusing drugs and prescription medica5 tions and resume their productive lives. 

6 (6) According to the Office of National Drug 

7 Control Policy (commonly referred to as 

8 ‘‘ONDCP’’), approximately 22,700,000 people in the 

9 United States needed substance use disorder treat10 ment in 2013, but only 2,500,000 people received it. 

11 (7) Effective substance abuse prevention can 

12 yield major economic dividends. Every dollar in13 vested in prevention can lead to savings between $2 

14 and $20. 

15 (8) According to the National Institute on Drug 

16 Abuse, when schools and communities properly im17 plement science-validated substance abuse prevention 

18 programs, alcohol, tobacco, and illicit drug abuse are 

19 reduced. Such programs help teachers, parents, and 

20 healthcare professionals shape the perceptions of 

21 youths about the risks of drug abuse. 

22 (9) Diverting individuals with substance use 

23 disorders from criminal justice systems into commu24 nity-based treatment can save billions of dollars and 

25 prevent sizeable numbers of crimes, arrests, and reVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
5 

•S 2839 IS

1 incarcerations over the course of those individuals’ 

2 lives. 

3 (10) According to the Drug Enforcement Agen4 cy, more than 1,700 tons of expired, unwanted pre5 scription medications have been collected over the 

past 31 6 ⁄2 years, following the enactment of the Se7 cure and Responsible Drug Disposal Act of 2010 

8 (Public Law 111–273; 124 Stat. 2858). 

9 (11) Research shows that combining treatment 

10 medications with behavioral therapy is the best way 

11 to ensure success for most patients. Treatment ap12 proaches must be tailored to address the drug abuse 

13 patterns and drug-related medical, psychiatric, and 

14 social problems of each individual. Different types of 

15 medications may be useful at different stages of 

16 treatment to help a patient stop abusing drugs, stay 

17 in treatment, and avoid relapse. 

18 (12) Research indicates that combating the epi19 demic of opioid abuse, including abuse of prescrip20 tion painkillers and, increasingly, heroin, requires a 

21 multi-pronged approach that involves reducing drug 

22 diversion, expanding delivery of existing treatments 

23 (including medication assisted treatments), expand24 ing access to overdose medications and interventions, 


emcdonald on DSK67QTVN1PROD with BILLS
6 

•S 2839 IS

1 and the development of new medications for pain 

2 that can augment the existing treatment arsenal. 

3 SEC. 3. DEFINITIONS. 

4 In this Act— 

5 (1) the term ‘‘Indian tribe’’ has the meaning 

6 given the term in section 4 of the Indian Self-Deter7 mination and Education Assistance Act (25 U.S.C. 

8 450b); 

9 (2) the term ‘‘medication assisted treatment’’ 

10 means the use, for problems relating to heroin and 

11 other opioids, of medications approved by the Food 

12 and Drug Administration in combination with coun13 seling and behavioral therapies.; 

14 (3) the term ‘‘ONDCP Recovery Branch’’ 

15 means the Recovery Branch of the Office of Na16 tional Drug Control Policy; 

17 (4) the term ‘‘opioid’’ means any drug having 

18 an addiction-forming or addiction-sustaining liability 

19 similar to morphine or being capable of conversion 

20 into a drug having such addiction-forming or addic21 tion-sustaining liability; 

22 (5) the term ‘‘Single State Authority for Sub23 stance Abuse’’ has the meaning given the term in 

24 section 201(e) of the Second Chance Act of 2007 

25 (42 U.S.C. 17521(e)); and 


emcdonald on DSK67QTVN1PROD with BILLS
7 

•S 2839 IS

1 (6) the term ‘‘State’’ means any State of the 

2 United States, the District of Columbia, the Com3 monwealth of Puerto Rico, and any territory or pos4 session of the United States. 

5 TITLE I—PREVENTION AND 

6 EDUCATION 

7 SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRAC8 TICES. 

9 (a) INTER-AGENCY TASK FORCE.—Not later than 

10 120 days after the date of enactment of this Act, the Sec11 retary of Health and Human Services (referred to in this 

12 section as the ‘‘Secretary’’), in cooperation with the Sec13 retary of Veterans Affairs, the Secretary of Defense, and 

14 the Administrator of the Drug Enforcement Administra15 tion, shall convene a Pain Management Best Practices 

16 Inter-Agency Task Force (referred to in this section as 

17 the ‘‘task force’’). 

18 (b) MEMBERSHIP.—The task force shall be com19 prised of— 

20 (1) representatives of— 

21 (A) the Department of Health and Human 

22 Services; 

23 (B) the Department of Veterans Affairs; 

24 (C) the Department of Defense; 

25 (D) the Drug Enforcement Administration; 


emcdonald on DSK67QTVN1PROD with BILLS
8 

•S 2839 IS

1 (E) the Centers for Disease Control and 

2 Prevention; 

3 (F) the Institute of Medicine; and 

4 (G) the Office of National Drug Control 

5 Policy; 

6 (2) the Director of the National Institutes of 

7 Health; 

8 (3) physicians, dentists, and non-physician pre9 scribers; 

10 (4) pharmacists; 

11 (5) experts in the fields of pain research and 

12 addiction research; 

13 (6) representatives of— 

14 (A) pain management professional organi15 zations; 

16 (B) the mental health treatment commu17 nity; 

18 (C) the addiction treatment community; 

19 and 

20 (D) pain advocacy groups; and 

21 (7) other stakeholders, as the Secretary deter22 mines appropriate. 

23 (c) DUTIES.—The task force shall— 

24 (1) not later than 180 days after the date on 

25 which the task force is convened under subsection 


emcdonald on DSK67QTVN1PROD with BILLS
9 

•S 2839 IS

1 (a), develop best practices for pain management and 

2 prescribing pain medication, taking into consider3 ation— 

4 (A) existing pain management research; 

5 (B) recommendations from relevant con6 ferences; and 

7 (C) ongoing efforts at the State and local 

8 levels and by medical professional organizations 

9 to develop improved pain management strate10 gies; 

11 (2) solicit and take into consideration public 

12 comment on the practices developed under para13 graph (1), amending such best practices if appro14 priate; and 

15 (3) develop a strategy for disseminating infor16 mation about the best practices developed under 

17 paragraphs (1) and (2) to prescribers, pharmacists, 

18 State medical boards, and other parties, as the Sec19 retary determines appropriate. 

20 (d) LIMITATION.—The task force shall not have rule21 making authority. 

22 (e) REPORT.—Not later than 270 days after the date 

23 on which the task force is convened under subsection (a), 

24 the task force shall submit to Congress a report that in25 cludes— 


emcdonald on DSK67QTVN1PROD with BILLS
10 

•S 2839 IS

1 (1) the strategy for disseminating best practices 

2 developed under subsection (c); 

3 (2) the results of a feasibility study on linking 

4 best practices developed under subsection (c) to re5 ceiving and renewing registrations under section 

6 303(f) of the Controlled Substances Act (21 U.S.C. 

7 823(f)); and 

8 (3) recommendations on how to apply best 

9 practices developed under subsection (c) to improve 

10 prescribing practices at medical facilities, including 

11 medical facilities of the Veterans Health Administra12 tion. 

13 SEC. 102. NATIONAL EDUCATION CAMPAIGN. 

14 (a) DEFINITION.—In this section, the term ‘‘eligible 

15 entity’’ means a State, unit of local government, or non16 profit organization. 

17 (b) PROGRAM AUTHORIZED.—The Attorney General, 

18 in coordination with the Secretary of Health and Human 

19 Services, the Director of the Office of National Drug Con20 trol Policy, the Secretary of Education, the Administrator 

21 of the Substance Abuse and Mental Health Services Ad22 ministration, and the Director of the Centers for Disease 

23 Control and Prevention, may make grants to eligible enti24 ties to expand educational efforts to prevent abuse of 

25 opioids, heroin, and other substances of abuse, understand 


emcdonald on DSK67QTVN1PROD with BILLS
11 

•S 2839 IS

1 addiction as a chronic disease, and promote treatment and 

2 recovery, including— 

3 (1) parent and caretaker-focused prevention ef4 forts, including— 

5 (A) the development of research-based 

6 community education online and social media 

7 materials with an accompanying toolkit that 

8 can be disseminated to communities to educate 

9 parents and other caretakers of teens on— 

10 (i) how to educate teens about opioid 

11 and heroin abuse; 

12 (ii) how to intervene if a parent thinks 

13 or knows their teen is abusing opioids or 

14 heroin; 

15 (iii) signs of opioid or heroin overdose; 

16 and 

17 (iv) the use of naloxone to prevent 

18 death from opioid or heroin overdose; 

19 (B) the development of detailed digital and 

20 print educational materials to accompany the 

21 online and social media materials and toolkit 

22 described in subparagraph (A); 

23 (C) the development and dissemination of 

24 public service announcements to— 


emcdonald on DSK67QTVN1PROD with BILLS
12 

•S 2839 IS

1 (i) raise awareness of heroin and 

2 opioid abuse among parents and other 

3 caretakers; and 

4 (ii) motivate parents and other care5 takers to visit online educational materials 

6 on heroin and opioid abuse; and 

7 (D) the dissemination of educational mate8 rials to the media through— 

9 (i) a town hall or panel discussion 

10 with experts; 

11 (ii) a press release; 

12 (iii) an online news release; 

13 (iv) a media tour; and 

14 (v) sharable infographics; 

15 (2) prevention efforts focused on teenagers, col16 lege students, and college-age individuals, includ17 ing— 

18 (A) the development of a national digital 

19 campaign; and 

20 (B) the development of a community edu21 cation toolkit for use by community coalitions; 

22 (3) campaigns to inform individuals about avail23 able resources to aid in recovery from substance use 

24 disorder; 


emcdonald on DSK67QTVN1PROD with BILLS
13 

•S 2839 IS

1 (4) encouragement of individuals in or seeking 

2 recovery from substance use disorder to enter the 

3 health care system; or 

4 (5) adult-focused awareness efforts, including 

5 efforts focused on older adults, relating to prescrip6 tion medication disposal, opioid and heroin abuse, 

7 signs of overdose, and the use of naloxone for rever8 sal. 

9 (c) APPLICATION.— 

10 (1) IN GENERAL.—An eligible entity desiring a 

11 grant under this section shall submit an application 

12 to the Attorney General— 

13 (A) that meets the criteria under para14 graph (2); and 

15 (B) at such time, in such manner, and ac16 companied by such information as the Attorney 

17 General may require. 

18 (2) CRITERIA.—An eligible entity, in submitting 

19 an application under paragraph (1), shall— 

20 (A) describe the evidence-based method21 ology and outcome measurements that will be 

22 used to evaluate the program funded with a 

23 grant under this section; 

24 (B) specifically explain how the measure25 ments described in subparagraph (A) will proVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00013 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
14 

•S 2839 IS

1 vide valid measures of the impact of the pro2 gram described in subparagraph (A); 

3 (C) describe how the program described in 

4 subparagraph (A) could be broadly replicated if 

5 demonstrated to be effective; 

6 (D) demonstrate that all planned services 

7 will be research-informed, which may include 

8 evidence-based practices documented in— 

9 (i) the report of the Institute of Medi10 cine entitled ‘‘Preventing Mental, Emo11 tional, and Behavioral Disorders Among 

12 Young People’’; or 

13 (ii) the National Registry of Effective 

14 Programs and Practices (commonly re15 ferred to as ‘‘NREPP’’ of the Substance 

16 Abuse and Mental Health Administration); 

17 and 

18 (E) demonstrate that the eligible entity 

19 will effectively integrate and sustain the pro20 gram described in subparagraph (A) into cur21 riculum or community outreach efforts. 

22 (d) USE OF FUNDS.—A grantee shall use a grant re23 ceived under this section for expenses of educational ef24 forts to— 


emcdonald on DSK67QTVN1PROD with BILLS
15 

•S 2839 IS

1 (1) prevent abuse of opioids, heroin, alcohol, 

2 and other drugs; or 

3 (2) promote treatment and recovery. 

4 (e) DURATION.—The Attorney General shall award 

5 grants under this section for a period not to exceed 2 

6 years. 

7 (f) INFORMATION SHARING.—The Office of the At8 torney General, in coordination with the Substance Abuse 

9 and Mental Health Services Administration and the De10 partment of Education, shall review existing evidence11 based programs and emerging practices and programs and 

12 provide information to schools and communities about 

13 such programs and practices. 

14 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

15 are authorized to be appropriated to carry out this section 

16 $2,500,000 for each of fiscal years 2016 through 2020. 

17 SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 

18 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

19 (a) DEFINITIONS.—In this section— 

20 (1) the term ‘‘Drug-Free Communities Act of 

21 1997’’ means chapter 2 of subtitle A of title I of the 

22 Anti-Drug Abuse Act of 1988 (21 U.S.C. 1521 et 

23 seq.); 

24 (2) the term ‘‘eligible entity’’ means an organi25 zation that— 


emcdonald on DSK67QTVN1PROD with BILLS
16 

•S 2839 IS

1 (A) on or before the date of submitting an 

2 application for a grant under this section, re3 ceives or has received a grant under the Drug4 Free Communities Act of 1997; and 

5 (B) has documented, using local data, 

6 rates of abuse of opioids at levels that are— 

7 (i) significantly higher than the na8 tional average as determined by the Attor9 ney General (including appropriate consid10 eration of the Monitoring the Future Sur11 vey published by the National Institute on 

12 Drug Abuse and the National Survey on 

13 Drug Use and Health by the Substance 

14 Abuse and Mental Health Service Adminis15 tration); or 

16 (ii) higher than the national average, 

17 as determined by the Attorney General (in18 cluding appropriate consideration of the 

19 surveys described in clause (i)), over a sus20 tained period of time; and 

21 (3) the term ‘‘local drug crisis’’ means, with re22 spect to the area served by an eligible entity— 

23 (A) a sudden increase in the abuse of pre24 scription medications, specifically opioids, as 

25 documented by local data; or 


emcdonald on DSK67QTVN1PROD with BILLS
17 

•S 2839 IS

1 (B) the abuse of prescription medications, 

2 specifically opioids, that is significantly higher 

3 than the national average, over a sustained pe4 riod of time, as documented by local data. 

5 (b) PROGRAM AUTHORIZED.—The Attorney General, 

6 in coordination with the Director of the Office of National 

7 Drug Control Policy, may make grants to eligible entities 

8 to implement comprehensive community-wide strategies 

9 that address local drug crises within the area served by 

10 the eligible entity. 

11 (c) APPLICATION.— 

12 (1) IN GENERAL.—An eligible entity desiring a 

13 grant under this section shall submit an application 

14 to the Attorney General at such time, in such man15 ner, and accompanied by such information as the 

16 Attorney General may require. 

17 (2) CRITERIA.—As part of an application for a 

18 grant under this section, the Attorney General shall 

19 require an eligible entity to submit a detailed, com20 prehensive, multi-sector plan for addressing the local 

21 drug crisis within the area served by the eligible en22 tity. 

23 (d) USE OF FUNDS.—An eligible entity shall use a 

24 grant received under this section— 


emcdonald on DSK67QTVN1PROD with BILLS
18 

•S 2839 IS

1 (1) for programs designed to implement com2 prehensive community-wide prevention strategies to 

3 address local drug crisis in the area served by the 

4 eligible entity, in accordance with the plan submitted 

5 under subsection (c)(2); and 

6 (2) to obtain specialized training and technical 

7 assistance from the organization funded under sec8 tion 4 of Public Law 107–82 (21 U.S.C. 1521 note). 

9 (e) GRANT AMOUNTS AND DURATION.— 

10 (1) AMOUNTS.—The Attorney General may not 

11 award a grant under this section for a fiscal year in 

12 an amount that exceeds— 

13 (A) the amount of non-Federal funds 

14 raised by the eligible entity, including in-kind 

15 contributions, for that fiscal year; or 

16 (B) $75,000. 

17 (2) DURATION.—The Attorney General shall 

18 award grants under this section for a period not to 

19 exceed 4 years. 

20 (f) SUPPLEMENT NOT SUPPLANT.—An eligible entity 

21 shall use Federal funds received under this section only 

22 to supplement the funds that would, in the absence of 

23 those Federal funds, be made available from other Federal 

24 and non-Federal sources for the activities described in this 

25 section, and not to supplant those funds. 


emcdonald on DSK67QTVN1PROD with BILLS
19 

•S 2839 IS

1 (g) EVALUATION.—A grant under this section shall 

2 be subject to the same evaluation requirements and proce3 dures as the evaluation requirements and procedures im4 posed on the recipient of a grant under the Drug-Free 

5 Communities Act of 1997. 

6 (h) LIMITATION ON ADMINISTRATIVE EXPENSES.— 

7 Not more than 8 percent of the amounts made available 

8 pursuant to subsection (i) for a fiscal year may be used 

9 by the Attorney General to pay for administrative ex10 penses. 

11 (i) AUTHORIZATION OF APPROPRIATIONS.—There 

12 are authorized to be appropriated to carry out this section 

13 $5,000,000 for each of fiscal years 2016 through 2020. 

14 TITLE II—LAW ENFORCEMENT 

15 AND TREATMENT 

16 SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 

17 PROGRAMS. 

18 (a) DEFINITIONS.—In this section— 

19 (1) the term ‘‘eligible entity’’ means a State, 

20 unit of local government, Indian tribe, or nonprofit 

21 organization; and 

22 (2) the term ‘‘eligible participant’’ means an in23 dividual who— 

24 (A) comes into contact with the criminal 

25 justice system or is charged with an offense; 


emcdonald on DSK67QTVN1PROD with BILLS
20 

•S 2839 IS

1 (B) has a history of or a current— 

2 (i) substance use disorder; 

3 (ii) mental illness; or 

4 (iii) co-occurring mental illness and 

5 substance use disorders; and 

6 (C) has been unanimously approved for 

7 participation in a program funded under this 

8 section by, as applicable depending on the stage 

9 of the criminal justice process, the relevant 

10 prosecuting attorney, defense attorney, proba11 tion or corrections official, judge, or representa12 tive from the relevant mental health or sub13 stance abuse agency. 

14 (b) PROGRAM AUTHORIZED.—The Attorney General 

15 may make grants to eligible entities to develop, implement, 

16 or expand a treatment alternative to incarceration pro17 gram for eligible participants, including— 

18 (1) pre-booking treatment alternative to incar19 ceration programs, including— 

20 (A) law enforcement training on substance 

21 use disorders, mental illness, and co-occurring 

22 mental illness and substance use disorders; 

23 (B) receiving centers as alternatives to in24 carceration of eligible participants; 


emcdonald on DSK67QTVN1PROD with BILLS
21 

•S 2839 IS

1 (C) specialized response units for calls re2 lated to substance use disorders, mental illness, 

3 and co-occurring mental illness and substance 

4 use disorders; and 

5 (D) other arrest and pre-booking treat6 ment alternative to incarceration models; and 

7 (2) post-booking treatment alternative to incar8 ceration programs, including— 

9 (A) specialized clinical case management; 

10 (B) pre-trial services related to substances 

11 use disorders, mental illness, and co-occurring 

12 mental illness and substance use disorders; 

13 (C) prosecutor and defender based pro14 grams; 

15 (D) specialized probation; 

16 (E) treatment and rehabilitation programs; 

17 and 

18 (F) drug courts, DWI courts, and veterans 

19 treatment courts. 

20 (c) APPLICATION.— 

21 (1) IN GENERAL.—An eligible entity desiring a 

22 grant under this section shall submit an application 

23 to the Attorney General— 

24 (A) that meets the criteria under para25 graph (2); and 


emcdonald on DSK67QTVN1PROD with BILLS
22 

•S 2839 IS

1 (B) at such time, in such manner, and ac2 companied by such information as the Attorney 

3 General may require. 

4 (2) CRITERIA.—An eligible entity, in submitting 

5 an application under paragraph (1), shall— 

6 (A) provide extensive evidence of collabora7 tion with State and local government agencies 

8 overseeing health, community corrections, 

9 courts, prosecution, substance abuse, mental 

10 health, victims services, and employment serv11 ices, and with local law enforcement agencies; 

12 (B) demonstrate consultation with the Sin13 gle State Authority for Substance Abuse; 

14 (C) demonstrate that evidence-based treat15 ment practices will be utilized; and 

16 (D) demonstrate that evidenced-based 

17 screening and assessment tools will be utilized 

18 to place participants in the treatment alter19 native to incarceration program. 

20 (d) REQUIREMENTS.—Each eligible entity awarded a 

21 grant for a treatment alternative to incarceration program 

22 under this section shall— 

23 (1) determine the terms and conditions of par24 ticipation in the program by eligible participants, 


emcdonald on DSK67QTVN1PROD with BILLS
23 

•S 2839 IS

1 taking into consideration the collateral consequences 

2 of criminal conviction; 

3 (2) ensure that each substance abuse and men4 tal health treatment component is licensed and 

5 qualified by the relevant jurisdiction; 

6 (3) for programs described in subsection (b)(2), 

7 organize an enforcement unit comprised of appro8 priately trained law enforcement professionals under 

9 the supervision of the State, Tribal, or local criminal 

10 justice agency involved, the duties of which shall in11 clude— 

12 (A) the verification of addresses and other 

13 contacts of each eligible participant who partici14 pates or desires to participate in the program; 

15 and 

16 (B) if necessary, the location, apprehen17 sion, arrest, and return to court of an eligible 

18 participant in the program who has absconded 

19 from the facility of a treatment provider or has 

20 otherwise violated the terms and conditions of 

21 the program, consistent with Federal and State 

22 confidentiality requirements; 

23 (4) notify the relevant criminal justice entity if 

24 any eligible participant in the program absconds 

25 from the facility of the treatment provider or otherVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00023 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
24 

•S 2839 IS

1 wise violates the terms and conditions of the pro2 gram, consistent with Federal and State confiden3 tiality requirements; 

4 (5) submit periodic reports on the progress of 

5 treatment of each eligible offender participating in 

6 the program to the relevant State, Tribal, or local 

7 criminal justice agency; 

8 (6) describe the evidence-based methodology 

9 and outcome measurements that will be used to 

10 evaluate the program, and specifically explain how 

11 such measurements will provide valid measures of 

12 the impact of the program; and 

13 (7) describe how the program could be broadly 

14 replicated if demonstrated to be effective. 

15 (e) USE OF FUNDS.—An eligible entity shall use a 

16 grant received under this section for expenses of a treat17 ment alternative to incarceration program, including— 

18 (1) salaries, personnel costs, equipment costs, 

19 and other costs directly related to the operation of 

20 the program, including the enforcement unit; 

21 (2) payments for treatment providers that are 

22 approved by the relevant State or Tribal jurisdiction 

23 and licensed, if necessary, to provide needed treat24 ment to eligible offenders participating in the proVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00024 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
25 

•S 2839 IS

1 gram, including aftercare supervision, vocational 

2 training, education, and job placement; and 

3 (3) payments to public and nonprofit private 

4 entities that are approved by the State or Tribal ju5 risdiction and licensed, if necessary, to provide alco6 hol and drug addiction treatment to eligible offend7 ers participating in the program. 

8 (f) SUPPLEMENT NOT SUPPLANT.—An eligible entity 

9 shall use Federal funds received under this section only 

10 to supplement the funds that would, in the absence of 

11 those Federal funds, be made available from other Federal 

12 and non-Federal sources for the activities described in this 

13 section, and not to supplant those funds. 

14 (g) GEOGRAPHIC DISTRIBUTION.—The Attorney 

15 General shall ensure that, to the extent practicable, the 

16 geographical distribution of grants under this section is 

17 equitable and includes a grant to an eligible entity in— 

18 (1) each State; 

19 (2) rural, suburban, and urban areas; and 

20 (3) Tribal jurisdictions. 

21 (h) REPORTS AND EVALUATIONS.—Each fiscal year, 

22 each recipient of a grant under this section during that 

23 fiscal year shall submit to the Attorney General a report 

24 on the outcomes of activities carried out using that grant 


emcdonald on DSK67QTVN1PROD with BILLS
26 

•S 2839 IS

1 in such form, containing such information, and on such 

2 dates as the Attorney General shall specify. 

3 (i) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated to carry out this section 

5 $5,000,000 for each of fiscal years 2016 through 2020. 

6 SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND 

7 IMPLEMENTATION PILOT. 

8 (a) DEFINITION.—In this section, the term ‘‘eligible 

9 entity’’ means a State, local, or tribal law enforcement 

10 agency. 

11 (b) PROGRAM AUTHORIZED.—The Attorney General, 

12 in coordination with the Secretary of Health and Human 

13 Services and the Director of the Office of National Drug 

14 Control Policy, may make grants to eligible entities to cre15 ate a pilot law enforcement program to prevent opioid and 

16 heroin overdose death. 

17 (c) APPLICATION.— 

18 (1) IN GENERAL.—An eligible entity desiring a 

19 grant under this section shall submit an application 

20 to the Attorney General— 

21 (A) that meets the criteria under para22 graph (2); and 

23 (B) at such time, in such manner, and ac24 companied by such information as the Attorney 

25 General may require. 


emcdonald on DSK67QTVN1PROD with BILLS
27 

•S 2839 IS

1 (2) CRITERIA.—An eligible entity, in submitting 

2 an application under paragraph (1), shall— 

3 (A) describe the evidence-based method4 ology and outcome measurements that will be 

5 used to evaluate the program funded with a 

6 grant under this section, and specifically ex7 plain how such measurements will provide valid 

8 measures of the impact of the program; 

9 (B) describe how the program could be 

10 broadly replicated if demonstrated to be effec11 tive; 

12 (C) identify the governmental and commu13 nity agencies that the program will coordinate; 

14 and 

15 (D) describe how law enforcement agencies 

16 will coordinate with their corresponding State 

17 substance abuse agency to identify protocols 

18 and resources that are available to victims and 

19 families, including information on treatment 

20 and recovery resources. 

21 (d) USE OF FUNDS.—An eligible entity shall use a 

22 grant received under this section to— 

23 (1) make naloxone available to be carried and 

24 administered by law enforcement officers; 


emcdonald on DSK67QTVN1PROD with BILLS
28 

•S 2839 IS

1 (2) train and provide resources for law enforce2 ment officers on carrying and administering 

3 naloxone for the prevention of opioid and heroin 

4 overdose death; and 

5 (3) establish processes, protocols, and mecha6 nisms for referral to treatment. 

7 (e) GRANT AMOUNTS AND DURATION.— 

8 (1) MAXIMUM AMOUNT.—The Attorney General 

9 may not award a grant under this section in an 

10 amount that exceeds $500,000. 

11 (2) DURATION.—The Attorney General shall 

12 award grants under this section for a period not to 

13 exceed 2 years. 

14 (f) TECHNICAL ASSISTANCE GRANTS.—The Attorney 

15 General shall make a grant for the purpose of providing 

16 technical assistance and training on the use of naloxone 

17 to reverse overdose deaths and mechanisms for referral to 

18 treatment for an eligible entity receiving a grant under 

19 this section. 

20 (g) EVALUATION.—The Attorney General shall con21 duct an evaluation of grants made under this section to 

22 determine— 

23 (1) the number of officers equipped with 

24 naloxone for the prevention of fatal opioid and her25 oin overdose; 


emcdonald on DSK67QTVN1PROD with BILLS
29 

•S 2839 IS

1 (2) the number of opioid and heroin overdoses 

2 reversed by officers receiving training and supplies 

3 of naloxone through a grant received under this sec4 tion; 

5 (3) the number of calls for service related to 

6 opioid and heroin overdose; 

7 (4) the extent to which overdose victims and 

8 families receive information about treatment services 

9 and available data describing treatment admissions; 

10 and 

11 (5) the research, training, and naloxone supply 

12 needs of law enforcement and first responder agen13 cies, including those agencies that are not receiving 

14 grants under this section. 

15 (h) AUTHORIZATION OF APPROPRIATIONS.—There 

16 are authorized to be appropriated to carry out this section 

17 $5,000,000 for each of fiscal years 2016 through 2020. 

18 SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

19 (a) DEFINITION.—In this section, the term ‘‘eligible 

20 entity’’ means a State, local, or tribal law enforcement 

21 agency. 

22 (b) PROGRAM AUTHORIZED.—The Attorney General, 

23 in coordination with the Administrator of the Drug En24 forcement Administration, the Secretary of Health and 

25 Human Services, and the Director of the Office of NaVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00029 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
30 

•S 2839 IS

1 tional Drug Control Policy, may make grants to eligible 

2 entities to expand or make available disposal sites for un3 wanted prescription medications. 

4 (c) APPLICATION.— 

5 (1) IN GENERAL.—An eligible entity desiring a 

6 grant under this section shall submit an application 

7 to the Attorney General— 

8 (A) that meets the criteria under para9 graph (2); and 

10 (B) at such time, in such manner, and ac11 companied by such information as the Attorney 

12 General may require. 

13 (2) CRITERIA.—An eligible entity, in submitting 

14 an application under paragraph (1), shall— 

15 (A) describe the evidence-based method16 ology and outcome measurements that will be 

17 used to evaluate the program funded with a 

18 grant under this section, and specifically ex19 plain how such measurements will provide valid 

20 measures of the impact of the program; 

21 (B) describe how the program could be 

22 broadly replicated if demonstrated to be effec23 tive; and 

24 (C) identify the governmental and commu25 nity agencies that the project will be coordinate. 


emcdonald on DSK67QTVN1PROD with BILLS
31 

•S 2839 IS

1 (d) USE OF FUNDS.—An eligible entity shall use a 

2 grant received under this section for— 

3 (1) expenses of a prescription drug disposal 

4 site, including materials and resources; 

5 (2) implementing disposal procedures and proc6 esses; 

7 (3) implementing community education strate8 gies, including community education materials and 

9 resources; 

10 (4) replicating a prescription drug take back 

11 initiative throughout multiple jurisdictions; and 

12 (5) training of law enforcement officers and 

13 other community participants. 

14 (e) GRANT AMOUNTS AND DURATION.— 

15 (1) MAXIMUM AMOUNT.—The Attorney General 

16 may not award a grant under this section in an 

17 amount that exceeds $250,000. 

18 (2) DURATION.—The Attorney General shall 

19 award grants under this section for a period not to 

20 exceed 2 years. 

21 (f) TECHNICAL ASSISTANCE GRANT.—The Attorney 

22 General shall make a grant to a national nonprofit organi23 zation to provide technical assistance and training for an 

24 eligible entity receiving a grant under this section. 

25 (g) EVALUATION.— 


emcdonald on DSK67QTVN1PROD with BILLS
32 

•S 2839 IS

1 (1) IN GENERAL.—The Attorney General shall 

2 make a grant for evaluation of the performance of 

3 each eligible entity receiving a grant under this sec4 tion. 

5 (2) REPORTS.—Each fiscal year, the recipient 

6 of a grant under this subsection shall submit to the 

7 Attorney General a report on the effectiveness of the 

8 prescription drug take back program of each eligible 

9 entity receiving a grant under this section. 

10 (h) AUTHORIZATION OF APPROPRIATIONS.—There 

11 are authorized to be appropriated to carry out this section 

12 $2,500,000 for each of fiscal years 2016 through 2020. 

13 TITLE III—TREATMENT AND 

14 RECOVERY 

15 SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT16 MENT AND INTERVENTIONS DEMONSTRA17 TION. 

18 Subpart 1 of part B of title V of the Public Health 

19 Service Act (42 U.S.C. 290bb et seq.) is amended— 

20 (1) by redesignating section 514 (42 U.S.C. 

21 290bb–9), as added by section 3632 of the Meth22 amphetamine Anti-Proliferation Act of 2000 (Public 

23 Law 106–310; 114 Stat. 1236), as section 514B; 

24 and 

25 (2) by adding at the end the following: 


emcdonald on DSK67QTVN1PROD with BILLS
33 

•S 2839 IS

1 ‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT2 MENT AND INTERVENTIONS DEMONSTRA3 TION. 

4 ‘‘(a) GRANTS.— 

5 ‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di6 rector of the Center for Substance Abuse Treatment 

7 (referred to in this section as the ‘Director’) may 

8 award grants to State substance abuse agencies, 

9 units of local government, nonprofit organizations, 

10 and Indian tribes or tribal organizations (as defined 

11 in section 4 of the Indian Health Care Improvement 

12 Act (25 U.S.C. 1603)) that have a high rate, or 

13 have had a rapid increase, in the use of heroin or 

14 other opioids, in order to permit such entities to ex15 pand activities, including an expansion in the avail16 ability of medication assisted treatment, with respect 

17 to the treatment of addiction in the specific geo18 graphical areas of such entities where there is a rate 

19 or rapid increase in the use of heroin or other 

20 opioids. 

21 ‘‘(2) RECIPIENTS.—The entities receiving 

22 grants under paragraph (1) shall be selected by the 

23 Director. 

24 ‘‘(3) NATURE OF ACTIVITIES.—The grant funds 

25 awarded under paragraph (1) shall be used for ac26 tivities that are based on reliable scientific evidence 


emcdonald on DSK67QTVN1PROD with BILLS
34 

•S 2839 IS

1 of efficacy in the treatment of problems related to 

2 heroin or other opioids. 

3 ‘‘(b) GEOGRAPHIC DISTRIBUTION.—The Director 

4 shall ensure that grants awarded under subsection (a) are 

5 distributed equitably among the various regions of the Na6 tion and among rural, urban, and suburban areas that are 

7 affected by the use of heroin or other opioids. 

8 ‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 

9 ‘‘(1) evaluate the activities supported by grants 

10 awarded under subsection (a); 

11 ‘‘(2) disseminate widely such significant infor12 mation derived from the evaluation as the Director 

13 considers appropriate; 

14 ‘‘(3) provide States, Indian tribes and tribal or15 ganizations, and providers with technical assistance 

16 in connection with the provision of treatment of 

17 problems related to heroin and other opioids; and 

18 ‘‘(4) fund only those applications that specifi19 cally support recovery services as a critical compo20 nent of the grant program. 

21 ‘‘(d) DEFINITION.—The term ‘medication assisted 

22 treatment’ means the use, for problems relating to heroin 

23 and other opioids, of medications approved by the Food 

24 and Drug Administration in combination with counseling 

25 and behavioral therapies. 


emcdonald on DSK67QTVN1PROD with BILLS
35 

•S 2839 IS

1 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 

2 ‘‘(1) IN GENERAL.—There are authorized to be 

3 appropriated to carry out this section $10,000,000 

4 for fiscal year 2016 and such sums as may be nec5 essary for each of fiscal years 2016 through 2020. 

6 ‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 

7 appropriated to carry out this section in any fiscal 

8 year, the lesser of 5 percent of such funds or 

9 $1,000,000 shall be available to the Director for 

10 purposes of carrying out subsection (c).’’. 

11 SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED 

12 TREATMENT AND INTERVENTIONS DEM13 ONSTRATION. 

14 (a) DEFINITIONS.—In this section— 

15 (1) the term ‘‘criminal justice agency’’ means a 

16 State, local, or tribal— 

17 (A) court; 

18 (B) prison; 

19 (C) jail; or 

20 (D) other agency that performs the admin21 istration of criminal justice, including prosecu22 tion, pretrial services, and community super23 vision; and 

24 (2) the term ‘‘eligible entity’’ means a State, 

25 unit of local government, or Indian tribe. 


emcdonald on DSK67QTVN1PROD with BILLS
36 

•S 2839 IS

1 (b) PROGRAM AUTHORIZED.—The Attorney General, 

2 in coordination with the Secretary of Health and Human 

3 Services and the Director of the Office of National Drug 

4 Control Policy, may make grants to eligible entities to im5 plement medication assisted treatment programs through 

6 criminal justice agencies. 

7 (c) APPLICATION.— 

8 (1) IN GENERAL.—An eligible entity desiring a 

9 grant under this section shall submit an application 

10 to the Attorney General— 

11 (A) that meets the criteria under para12 graph (2); and 

13 (B) at such time, in such manner, and ac14 companied by such information as the Attorney 

15 General may require. 

16 (2) CRITERIA.—An eligible entity, in submitting 

17 an application under paragraph (1), shall— 

18 (A) certify that each medication assisted 

19 treatment program funded with a grant under 

20 this section has been developed in consultation 

21 with the Single State Authority for Substance 

22 Abuse; and 

23 (B) describe how data will be collected and 

24 analyzed to determine the effectiveness of the 

25 program described in subparagraph (A). 


emcdonald on DSK67QTVN1PROD with BILLS
37 

•S 2839 IS

1 (d) USE OF FUNDS.—An eligible entity shall use a 

2 grant received under this section for expenses of— 

3 (1) a medication assisted treatment program, 

4 including the expenses of prescribing medications 

5 recognized by the Food and Drug Administration for 

6 opioid treatment in conjunction with psychological 

7 and behavioral therapy; 

8 (2) training criminal justice agency personnel 

9 and treatment providers on medication assisted 

10 treatment; 

11 (3) cross-training personnel providing behav12 ioral health and health services, administration of 

13 medicines, and other administrative expenses, includ14 ing required reports; and 

15 (4) the provision of recovery coaches who are 

16 responsible for providing mentorship and transition 

17 plans to individuals reentering society following in18 carceration or alternatives to incarceration. 

19 (e) GRANT AMOUNTS AND DURATION.— 

20 (1) MAXIMUM AMOUNT.—The Attorney General 

21 may not award a grant under this section in an 

22 amount that exceeds $750,000. 

23 (2) DURATION.—The Attorney General shall 

24 award grants under this section for a period not to 

25 exceed 2 years. 


emcdonald on DSK67QTVN1PROD with BILLS
38 

•S 2839 IS

1 (f) TECHNICAL ASSISTANCE.—The Attorney General, 

2 in coordination with the Director of the National Institute 

3 on Drug Abuse and the Secretary of Health and Human 

4 Services, shall provide technical assistance and training 

5 for an eligible entity receiving a grant under this section. 

6 (g) REPORTS.— 

7 (1) IN GENERAL.—An eligible entity receiving a 

8 grant under this subsection shall submit a report to 

9 the Attorney General on the outcomes of each grant 

10 received under this section for individuals receiving 

11 medication assisted treatment, based on— 

12 (A) the recidivism of the individuals; 

13 (B) the treatment outcomes of the individ14 uals, including maintaining abstinence from ille15 gal, unauthorized, and unprescribed opioids and 

16 heroin; 

17 (C) the housing status of the individuals; 

18 and 

19 (D) the employment status of the individ20 uals. 

21 (2) CONTENTS AND TIMING.—Each report de22 scribed in paragraph (1) shall be submitted annually 

23 in such form, containing such information, and on 

24 such dates as the Attorney General shall specify. 


emcdonald on DSK67QTVN1PROD with BILLS
39 

•S 2839 IS

1 (h) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $5,000,000 for each of fiscal years 2016 through 2020. 

4 SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 

5 (a) DEFINITIONS.—In this section: 

6 (1) ELIGIBLE ENTITY.—The term ‘‘eligible enti7 ty’’ means— 

8 (A) a high school that has been accredited 

9 as a recovery high school by the Association of 

10 Recovery High Schools; 

11 (B) an accredited high school that is seek12 ing to establish or expand recovery support 

13 services; 

14 (C) an institution of higher education; 

15 (D) a recovery program at a nonprofit col16 legiate institution; or 

17 (E) a nonprofit organization. 

18 (2) INSTITUTION OF HIGHER EDUCATION.—The 

19 term ‘‘institution of higher education’’ has the 

20 meaning given the term in section 101 of the Higher 

21 Education Act of 1965 (20 U.S.C. 1001). 

22 (3) RECOVERY PROGRAM.—The term ‘‘recovery 

23 program’’— 

24 (A) means a program to help individuals 

25 who are recovering from substance use disVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00039 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
40 

•S 2839 IS

1 orders to initiate, stabilize, and maintain 

2 healthy and productive lives in the community; 

3 and 

4 (B) includes peer-to-peer support and com5 munal activities to build recovery skills and 

6 supportive social networks. 

7 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

8 Branch, in consultation with the Secretary of Education, 

9 may award grants to eligible entities to enable the entities 

10 to— 

11 (1) provide substance use recovery support serv12 ices to young people in high school and enrolled in 

13 institutions of higher education; 

14 (2) help build communities of support for young 

15 people in recovery through a spectrum of activities 

16 such as counseling and healthy and wellness-oriented 

17 social activities; and 

18 (3) encourage initiatives designed to help young 

19 people achieve and sustain recovery from substance 

20 use disorders. 

21 (c) USE OF FUNDS.—Grants awarded under sub22 section (b) may be used for activities to develop, support, 

23 and maintain youth recovery support services, including— 

24 (1) the development and maintenance of a dedi25 cated physical space for recovery programs; 


emcdonald on DSK67QTVN1PROD with BILLS
41 

•S 2839 IS

1 (2) dedicated staff for the provision of recovery 

2 programs; 

3 (3) healthy and wellness-oriented social activi4 ties and community engagement; 

5 (4) establishment of recovery high schools; 

6 (5) coordination of recovery programs with— 

7 (A) substance use disorder treatment pro8 grams and systems; 

9 (B) primary care providers; 

10 (C) the criminal justice system, including 

11 the juvenile justice system; 

12 (D) employers; 

13 (E) housing services; 

14 (F) child welfare services; 

15 (G) institutions of secondary higher edu16 cation and institutions of higher education; and 

17 (H) other programs or services related to 

18 the welfare of an individual in recovery from a 

19 substance use disorder; 

20 (6) the development of peer-to-peer support 

21 programs or services; and 

22 (7) additional activities that help youths and 

23 young adults to achieve recovery from substance use 

24 disorders. 


emcdonald on DSK67QTVN1PROD with BILLS
42 

•S 2839 IS

1 (d) RESOURCE CENTER.—The ONDCP Recovery 

2 Branch shall establish a resource center to provide tech3 nical support to recipients of grants under this section. 

4 (e) AUTHORIZATION OF APPROPRIATIONS.—There 

5 are authorized to be appropriated to carry out this section 

6 $3,000,000 for fiscal year 2016 and each of the 5 suc7 ceeding fiscal years. 

8 SEC. 304. BUILDING COMMUNITIES OF RECOVERY. 

9 (a) DEFINITION.—In this section, the term ‘‘recovery 

10 community organization’’ means an independent nonprofit 

11 organization that— 

12 (1) mobilizes resources within and outside of 

13 the recovery community to increase the prevalence 

14 and quality of long-term recovery from substance 

15 use disorders; and 

16 (2) is wholly or principally governed by people 

17 in recovery for substance use disorders who reflect 

18 the community served. 

19 (b) GRANTS AUTHORIZED.—The ONDCP Recovery 

20 Branch, in consultation with the Substance Abuse and 

21 Mental Health Services Administration, may award grants 

22 to recovery community organizations to enable such orga23 nizations to develop, expand, and enhance recovery serv24 ices. 


emcdonald on DSK67QTVN1PROD with BILLS
43 

•S 2839 IS

1 (c) MAXIMUM GRANT AMOUNT.—The ONDCP Re2 covery Branch may not award a grant under this section 

3 in an amount that exceeds $200,000. 

4 (d) FEDERAL SHARE.—The Federal share of the 

5 costs of a program funded by a grant under this section 

6 may not exceed 50 percent. 

7 (e) USE OF FUNDS.—Grants awarded under sub8 section (b)— 

9 (1) shall be used to develop, expand, and en10 hance community and statewide recovery support 

11 services; and 

12 (2) may be used to— 

13 (A) advocate for individuals in recovery 

14 from substance use disorders; 

15 (B) build connections between recovery 

16 networks, between recovery community organi17 zations, and with other recovery support serv18 ices, including— 

19 (i) substance use disorder treatment 

20 programs and systems; 

21 (ii) primary care providers; 

22 (iii) the criminal justice system; 

23 (iv) employers; 

24 (v) housing services; 

25 (vi) child welfare agencies; and 


emcdonald on DSK67QTVN1PROD with BILLS
44 

•S 2839 IS

1 (vii) other recovery support services 

2 that facilitate recovery from substance use 

3 disorders; 

4 (C) reduce the stigma associated with sub5 stance use disorders; 

6 (D) conduct public education and outreach 

7 on issues relating to substance use disorders 

8 and recovery, including— 

9 (i) how to identify the signs of addic10 tion; 

11 (ii) the resources that are available 

12 for individuals struggling with addiction; 

13 (iii) the resources that are available to 

14 help support individuals in recovery; and 

15 (iv) information on the medical con16 sequences of substance use disorders, in17 cluding neonatal abstinence syndrome and 

18 potential infection with human immuno19 deficiency virus and viral hepatitis; and 

20 (E) carry out other activities that 

21 strengthen the network of community support 

22 for individuals in recovery. 

23 (f) RESOURCE CENTER.—The ONDCP Recovery 

24 Branch shall establish a resource center to provide tech25 nical assistance to recipients of grants under this section 


emcdonald on DSK67QTVN1PROD with BILLS
45 

•S 2839 IS

1 and to provide information to individuals seeking to sup2 port people in recovery from substance use disorders. 

3 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated to carry out this section 

5 $50,700,000 in fiscal year 2016 and each of the 3 suc6 ceeding fiscal years. 

7 TITLE IV—ADDRESSING 

8 COLLATERAL CONSEQUENCES 

9 SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION 

10 GRANT PROGRAM. 

11 Title I of the Omnibus Crime Control and Safe 

12 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amend13 ed— 

14 (1) by redesignating part KK as part LL; and 

15 (2) by inserting before part LL, as redesig16 nated, the following: 

17 ‘‘PART KK—CORRECTIONAL EDUCATION 

18 DEMONSTRATION GRANT PROGRAM 

19 ‘‘SEC. 3001. CORRECTIONAL EDUCATION DEMONSTRATION 

20 GRANT PROGRAM. 

21 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

22 entity’ means a State, unit of local government, nonprofit 

23 organization, or Indian Tribe. 

24 ‘‘(b) GRANT PROGRAM AUTHORIZED.—The Attorney 

25 General may make grants of not more than $750,000 to 


emcdonald on DSK67QTVN1PROD with BILLS
46 

•S 2839 IS

1 eligible entities to design, implement, and expand edu2 cational programs for offenders in prisons, jails, and juve3 nile facilities, including to pay for— 

4 ‘‘(1) basic education, secondary level academic 

5 education, high school equivalency examination prep6 aration, career technical education, and English as 

7 a second language instruction at the basic, sec8 ondary, or post-secondary levels, for adult and juve9 nile populations; 

10 ‘‘(2) screening and assessment of inmates to as11 sess education level, needs, occupational interest or 

12 aptitude, risk level, and other needs, and case man13 agement services; 

14 ‘‘(3) hiring and training of instructors and 

15 aides, reimbursement of non-corrections staff and 

16 experts, reimbursement of stipends paid to inmate 

17 tutors or aides, and the costs of training inmate tu18 tors and aides; 

19 ‘‘(4) instructional supplies and equipment, in20 cluding occupational program supplies and equip21 ment to the extent that the supplies and equipment 

22 are used for instructional purposes; 

23 ‘‘(5) partnerships and agreements with commu24 nity colleges, universities, and career technology eduVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00046 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
47 

•S 2839 IS

1 cation program providers, including tuition pay2 ments; 

3 ‘‘(6) certification programs providing recognized 

4 high school equivalency certificates and industry rec5 ognized credentials; and 

6 ‘‘(7) technology solutions to— 

7 ‘‘(A) meet the instructional, assessment, 

8 and information needs of correctional popu9 lations; and 

10 ‘‘(B) facilitate the continued participation 

11 of incarcerated students in community-based 

12 education programs after the students are re13 leased from incarceration. 

14 ‘‘(c) APPLICATION.—An eligible entity desiring a 

15 grant under this section shall submit to the Attorney Gen16 eral an application in such form and manner, at such time, 

17 and accompanied by such information as the Attorney 

18 General specifies. 

19 ‘‘(d) PRIORITY CONSIDERATIONS.—In awarding 

20 grants under this section, the Attorney General shall give 

21 priority to applicants that— 

22 ‘‘(1) assess the level of risk and need of in23 mates, including by— 

24 ‘‘(A) assessing the need for English as a 

25 second language instruction; 


emcdonald on DSK67QTVN1PROD with BILLS
48 

•S 2839 IS

1 ‘‘(B) conducting educational assessments; 

2 and 

3 ‘‘(C) assessing occupational interests and 

4 aptitudes; 

5 ‘‘(2) target educational services to assessed 

6 needs, including academic and occupational at the 

7 basic, secondary, or post-secondary level; 

8 ‘‘(3) target career technology education pro9 grams to— 

10 ‘‘(A) areas of identified occupational de11 mand; and 

12 ‘‘(B) employment opportunities in the com13 munities in which students are reasonably ex14 pected to reside post-release; 

15 ‘‘(4) include a range of appropriate educational 

16 opportunities at the basic, secondary, and post-sec17 ondary levels; 

18 ‘‘(5) include opportunities for students to attain 

19 industry recognized credentials; 

20 ‘‘(6) include partnership or articulation agree21 ments linking institutional education programs with 

22 community sited programs provided by adult edu23 cation program providers and accredited institutions 

24 of higher education, community colleges, and voca25 tional training institutions; and 


emcdonald on DSK67QTVN1PROD with BILLS
49 

•S 2839 IS

1 ‘‘(7) explicitly include career pathways models 

2 offering opportunities for incarcerated students to 

3 develop academic skills, in-demand occupational 

4 skills and credentials, occupational experience in in5 stitutional work programs or work release programs, 

6 and linkages with employers in the community, so 

7 that incarcerated students have opportunities to em8 bark on careers with strong prospects for both post9 release employment and advancement in a career 

10 ladder over time. 

11 ‘‘(e) REQUIREMENTS.—An eligible entity desiring a 

12 grant under this section shall— 

13 ‘‘(1) describe the evidence-based methodology 

14 and outcome measurements that will be used to 

15 evaluate each program funded with a grant under 

16 this section, and specifically explain how such meas17 urements will provide valid measures of the impact 

18 of the program; and 

19 ‘‘(2) describe how the program described in 

20 paragraph (1) could be broadly replicated if dem21 onstrated to be effective. 

22 ‘‘(f) CONTROL OF INTERNET ACCESS.—An entity 

23 that receives a grant under this section shall restrict ac24 cess to the Internet by prisoners, as appropriate, to ensure 

25 public safety. 


emcdonald on DSK67QTVN1PROD with BILLS
50 

•S 2839 IS

1 ‘‘SEC. 3002. AUTHORIZATION OF APPROPRIATIONS. 

2 ‘‘There are authorized to be appropriated $5,000,000 

3 to carry out this part for fiscal years 2016 through 

4 2020.’’. 

5 SEC. 402. REVISION OF FAFSA FORM. 

6 Section 483 of the Higher Education Act of 1965 (20 

7 U.S.C. 1090) is amended by adding at the end the fol8 lowing: 

9 ‘‘(i) CONVICTIONS.—The Secretary shall not include 

10 any question about the conviction of an applicant for the 

11 possession or sale of illegal drugs on the FAFSA (or any 

12 other form developed under subsection (a)).’’. 

13 SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COL14 LATERAL CONSEQUENCES. 

15 (a) DEFINITION.—In this section, the term ‘‘collat16 eral consequence’’ means a penalty, disability, or dis17 advantage— 

18 (1) imposed on an individual as a result of a 

19 criminal conviction but not as part of the judgment 

20 of the court that imposes the conviction; or 

21 (2) that an administrative agency, official, or 

22 civil court is authorized, but not required, to impose 

23 on an individual convicted of a felony, misdemeanor, 

24 or other criminal offense. 

25 (b) ESTABLISHMENT.— 


emcdonald on DSK67QTVN1PROD with BILLS
51 

•S 2839 IS

1 (1) IN GENERAL.—Not later than 30 days after 

2 the date of enactment of this Act, the Secretary of 

3 Health and Human Services (in this section referred 

4 to as the ‘‘Secretary’’) shall establish a bipartisan 

5 task force to be known as the Task Force on Recov6 ery and Collateral Consequences (in this section re7 ferred to as the ‘‘Task Force’’). 

8 (2) MEMBERSHIP.— 

9 (A) TOTAL NUMBER OF MEMBERS.—The 

10 Task Force shall include 9 members, who shall 

11 be appointed by the Secretary in accordance 

12 with subparagraphs (B) and (C). 

13 (B) MEMBERS OF THE TASK FORCE.—The 

14 Task Force shall include— 

15 (i) members who have national rec16 ognition and significant expertise in areas 

17 such as health care, housing, employment, 

18 substance use disorder, law enforcement, 

19 and law; 

20 (ii) not less than 1 member who has 

21 personally experienced addiction and is in 

22 recovery; and 

23 (iii) to the extent practicable, mem24 bers who formerly served as elected offi25 cials at the State and Federal levels. 


emcdonald on DSK67QTVN1PROD with BILLS
52 

•S 2839 IS

1 (C) TIMING.—The Secretary shall appoint 

2 the members of the Task Force not later than 

3 60 days after date on which the Task Force is 

4 established under paragraph (1). 

5 (3) CHAIRPERSON.—The Task Force shall se6 lect a chairperson or co-chairpersons from among 

7 the members of the Task Force. 

8 (c) DUTIES OF THE TASK FORCE.— 

9 (1) IN GENERAL.—The Task Force shall— 

10 (A) identify collateral consequences for in11 dividuals with Federal or State drug convictions 

12 who are in recovery for substance use disorder; 

13 and 

14 (B) determine whether the collateral con15 sequences identified under subparagraph (A) 

16 unnecessarily delay individuals in recovery from 

17 resuming their personal and professional activi18 ties. 

19 (2) RECOMMENDATIONS.—Not later than 180 

20 days after the date of the first meeting of the Task 

21 Force, the Task Force shall develop recommenda22 tions for proposed legislative and regulatory changes 

23 to reduce and, to the extent practicable, eliminate 

24 the collateral consequences identified by the Task 

25 Force under paragraph (1). 


emcdonald on DSK67QTVN1PROD with BILLS
53 

•S 2839 IS

1 (3) COLLECTION OF INFORMATION.—The Task 

2 Force shall hold hearings, require the testimony and 

3 attendance of witnesses, and secure information 

4 from any department or agency of the United States 

5 in performing the duties under paragraphs (1) and 

6 (2). 

7 (4) REPORT.—Not later than 1 year after the 

8 date of the first meeting of the Task Force, the 

9 Task Force shall submit a report detailing the find10 ings and recommendations of the Task Force to— 

11 (A) each relevant committee of Congress; 

12 (B) the head of each relevant department 

13 or agency of the United States; 

14 (C) the President; and 

15 (D) the Vice President. 

16 TITLE V—ADDICTION AND 

17 TREATMENT SERVICES FOR 

18 WOMEN, FAMILIES, AND VET19 ERANS 

20 SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO 

21 ADDRESS OPIOID AND HEROIN ABUSE BY 

22 PREGNANT AND PARENTING FEMALE OF23 FENDERS. 

24 (a) DEFINITIONS.—In this section— 


emcdonald on DSK67QTVN1PROD with BILLS
54 

•S 2839 IS

1 (1) the term ‘‘State criminal justice agency’’ 

2 means the agency of the State responsible for ad3 ministering criminal justice funds, including the Ed4 ward Byrne Memorial Justice Assistance Grant Pro5 gram under subpart 1 of part E of title I of the Om6 nibus Crime Control and Safe Streets Act of 1968 

7 (42 U.S.C. 3750 et seq.); and 

8 (2) the term ‘‘State substance abuse agency’’ 

9 means the agency of the State responsible for the 

10 State prevention, treatment, and recovery system, 

11 including management of the Substance Abuse Pre12 vention and Treatment Block Grant under subpart 

13 II of part B of title XIX of the Public Health Serv14 ice Act (42 U.S.C. 300x–21 et seq.). 

15 (b) PURPOSE AND PROGRAM AUTHORITY.— 

16 (1) GRANT AUTHORIZATION.—The Attorney 

17 General may award competitive grants jointly to a 

18 State substance abuse agency and a State criminal 

19 justice agency to address the use of opioids and her20 oin among pregnant and parenting female offenders 

21 in the State to promote public safety, public health, 

22 family permanence, and well-being. 

23 (2) PURPOSES AND PROGRAM AUTHORITY.—A 

24 grant under this section shall be used to facilitate or 

25 enhance collaboration between the State criminal 


emcdonald on DSK67QTVN1PROD with BILLS
55 

•S 2839 IS

1 justice and State substance abuse systems in order 

2 to carry out programs to address the use of opioid 

3 and heroin abuse by pregnant and parenting female 

4 offenders. 

5 (c) APPLICATIONS.— 

6 (1) IN GENERAL.—A State substance abuse 

7 agency and State criminal justice agency desiring a 

8 grant under this section shall jointly submit to the 

9 Attorney General an application in such form, and 

10 containing such information, as the Attorney Gen11 eral may prescribe by regulation or guidelines. 

12 (2) CONTENTS.— 

13 (A) IN GENERAL.—Each application for a 

14 grant under this section shall contain a plan to 

15 expand the services of the State for pregnant 

16 and parenting female offenders for the use of 

17 opioids, heroin, and other drugs, which shall be 

18 in accordance with regulations or guidelines es19 tablished by the Attorney General, in consulta20 tion with the Secretary of Health and Human 

21 Services. 

22 (B) PLAN.—A plan submitted under sub23 paragraph (A) shall, at a minimum, include— 

24 (i) a description of how the applicants 

25 will work jointly to address the needs assoVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00055 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
56 

•S 2839 IS

1 ciated with the use of opioids or heroin by 

2 pregnant and parenting female offenders 

3 to promote family stability and perma4 nence; 

5 (ii) a description of the nature and 

6 the extent of the problem of opioid and 

7 heroin use by pregnant and parenting fe8 male offenders in the State; 

9 (iii) a certification that the State has 

10 involved counties and other units of local 

11 government, when appropriate, in the de12 velopment, expansion, modification, oper13 ation, or improvement of proposed pro14 grams to address the problems associated 

15 with opioid and heroin use; 

16 (iv) a certification that funds received 

17 under this section will be used to supple18 ment, not supplant, other Federal, State, 

19 and local funds; and 

20 (v) a description of clinically appro21 priate practices and procedures to— 

22 (I) screen and assess pregnant 

23 and parenting female offenders for 

24 problems associated with opioids and 

25 heroin; 


emcdonald on DSK67QTVN1PROD with BILLS
57 

•S 2839 IS

1 (II) provide clinically appropriate 

2 services, including medication assisted 

3 treatment, for female offenders and 

4 their children in the same location to 

5 promote family permanence and self6 sufficiency; and 

7 (III) provide for a process to en8 hance or ensure the abilities of the 

9 State criminal justice agency and 

10 State substance abuse agency to work 

11 together to reunite families when ap12 propriate in the case where family 

13 treatment is not provided. 

14 (d) PERIOD OF GRANT; RENEWAL.— 

15 (1) PERIOD.—A grant under this section shall 

16 be for a period of 3 years. 

17 (2) RENEWAL.—A State substance abuse agen18 cy and a State criminal justice agency receiving a 

19 grant under this section may apply for and, after the 

20 end of the period of the first grant under this sec21 tion, receive 1 additional grant under this section. 

22 (e) PERFORMANCE ACCOUNTABILITY; REPORTS.— 

23 (1) REPORTS.—A State substance abuse agency 

24 and a State criminal justice agency receiving a grant 

25 under this section shall jointly submit to the AttorVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00057 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
58 

•S 2839 IS

1 ney General a report on the activities carried out 

2 under the grant at the end of each fiscal year during 

3 the period of the grant. 

4 (2) EVALUATION.—Not later than 1 year after 

5 the end of the period of a grant under this section, 

6 the Attorney General shall submit a report to each 

7 committee of Congress with jurisdiction of the pro8 gram under this section that summarizes the reports 

9 of the recipients of the grant and provides rec10 ommendations, if any, for further legislative action. 

11 (f) TRAINING AND TECHNICAL ASSISTANCE.—The 

12 Attorney General shall support State substance abuse and 

13 State criminal justice agencies by developing, in consulta14 tion with State substance abuse and State criminal justice 

15 agencies, and offering a program of training and technical 

16 assistance to assist the agencies in developing programs 

17 and protocols— 

18 (1) to implement this section; and 

19 (2) for effectively working across the Federal 

20 and State criminal and substance abuse systems. 

21 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

22 are authorized to be appropriated to carry out this section 

23 $5,000,000 for each of fiscal years 2016 through 2020. 


emcdonald on DSK67QTVN1PROD with BILLS
59 

•S 2839 IS

1 SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE 

2 TREATMENT. 

3 Section 2925 of the Omnibus Crime Control and Safe 

4 Streets Act of 1968 (42 U.S.C. 3797s–4) is amended— 

5 (1) by striking ‘‘An entity’’ and inserting ‘‘(a) 

6 ENTITY REPORTS.—An entity’’; and 

7 (2) by adding at the end the following: 

8 ‘‘(b) ATTORNEY GENERAL REPORT ON FAMILY9 BASED SUBSTANCE ABUSE TREATMENT.—The Attorney 

10 General shall submit to Congress an annual report that 

11 describes the number of grants awarded under section 

12 2921(1) and how such grants are used by the recipients 

13 for family-based substance abuse treatment programs that 

14 serve as alternatives to incarceration for custodial parents 

15 to receive treatment and services as a family.’’. 

16 SEC. 503. VETERANS’ TREATMENT COURTS. 

17 Section 2991 of the Omnibus Crime Control and Safe 

18 Streets Act of 1968 (42 U.S.C. 3797aa) is amended— 

19 (1) by redesignating subsection (i) as subsection 

20 (j); 

21 (2) by inserting after subsection (h) the fol22 lowing: 

23 ‘‘(i) ASSISTING VETERANS.— 

24 ‘‘(1) DEFINITIONS.—In this subsection: 

25 ‘‘(A) PEER TO PEER SERVICES OR PRO26 GRAMS.—The term ‘peer to peer services or 


emcdonald on DSK67QTVN1PROD with BILLS
60 

•S 2839 IS

1 programs’ means services or programs that con2 nect qualified veterans with other veterans for 

3 the purpose of providing support and 

4 mentorship to assist qualified veterans in ob5 taining treatment, recovery, stabilization, or re6 habilitation. 

7 ‘‘(B) QUALIFIED VETERAN.—The term 

8 ‘qualified veteran’ means a preliminarily quali9 fied offender who— 

10 ‘‘(i) has served on active duty in any 

11 branch of the Armed Forces, including the 

12 National Guard and reserve components; 

13 and 

14 ‘‘(ii) was discharged or released from 

15 such service under conditions other than 

16 dishonorable. 

17 ‘‘(C) VETERANS TREATMENT COURT PRO18 GRAM.—The term ‘veterans treatment court 

19 program’ means a court program involving col20 laboration among criminal justice, veterans, and 

21 mental health and substance abuse agencies 

22 that provides qualified veterans with— 

23 ‘‘(i) intensive judicial supervision and 

24 case management, which may include ranVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00060 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
61 

•S 2839 IS

1 dom and frequent drug testing where ap2 propriate; 

3 ‘‘(ii) a full continuum of treatment 

4 services, including mental health services, 

5 substance abuse services, medical services, 

6 and services to address trauma; 

7 ‘‘(iii) alternatives to incarceration; 

8 and 

9 ‘‘(iv) other appropriate services, in10 cluding housing, transportation, mentoring, 

11 employment, job training, education, and 

12 assistance in applying for and obtaining 

13 available benefits. 

14 ‘‘(2) VETERANS ASSISTANCE PROGRAM.— 

15 ‘‘(A) IN GENERAL.—The Attorney General, 

16 in consultation with the Secretary of Veterans 

17 Affairs, may award grants under this sub18 section to applicants to establish or expand— 

19 ‘‘(i) veterans treatment court pro20 grams; 

21 ‘‘(ii) peer to peer services or programs 

22 for qualified veterans; 

23 ‘‘(iii) practices that identify and pro24 vide treatment, rehabilitation, legal, transi25 tional, and other appropriate services to 


emcdonald on DSK67QTVN1PROD with BILLS
62 

•S 2839 IS

1 qualified veterans who have been incarcer2 ated; and 

3 ‘‘(iv) training programs to teach 

4 criminal justice, law enforcement, correc5 tions, mental health, and substance abuse 

6 personnel how to identify and appro7 priately respond to incidents involving 

8 qualified veterans. 

9 ‘‘(B) PRIORITY.—In awarding grants 

10 under this subsection, the Attorney General 

11 shall give priority to applications that— 

12 ‘‘(i) demonstrate collaboration be13 tween and joint investments by criminal 

14 justice, mental health, substance abuse, 

15 and veterans service agencies; 

16 ‘‘(ii) promote effective strategies to 

17 identify and reduce the risk of harm to 

18 qualified veterans and public safety; and 

19 ‘‘(iii) propose interventions with em20 pirical support to improve outcomes for 

21 qualified veterans.’’; and 

22 (3) in subsection (j), as so redesignated— 

23 (A) by redesignating paragraph (2) as 

24 paragraph (3); and 


emcdonald on DSK67QTVN1PROD with BILLS
63 

•S 2839 IS

1 (B) by inserting after paragraph (1) the 

2 following: 

3 ‘‘(2) VETERANS TREATMENT COURTS.—In addi4 tion to the amounts authorized under paragraph (1), 

5 there are authorized to be appropriated to the Attor6 ney General $5,000,000 for each of fiscal years 

7 2016 through 2020 to carry out subsection (i).’’. 

8 TITLE VI—INCENTIVIZING STATE 

9 COMPREHENSIVE INITIA10 TIVES TO ADDRESS OPIOID 

11 AND HEROIN ABUSE 

12 SEC. 601. STATE DEMONSTRATION GRANTS FOR COM13 PREHENSIVE OPIOID ABUSE RESPONSE. 

14 (a) DEFINITIONS.—In this section— 

15 (1) the term ‘‘civil liability protection law’’ 

16 means a State law that protects from civil liability 

17 individuals who give aid on a voluntary basis in an 

18 emergency to individuals who are ill, in peril, or oth19 erwise incapacitated; 

20 (2) the term ‘‘dispenser’’ has the meaning given 

21 the term in section 102 of the Controlled Substances 

22 Act (21 U.S.C. 802); 

23 (3) the term ‘‘prescriber of a schedule II, III, 

24 or IV controlled substance’’ does not include a preVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00063 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
64 

•S 2839 IS

1 scriber of a schedule II, III, or IV controlled sub2 stance that dispenses the substance— 

3 (A) for use on the premises on which the 

4 substance is dispensed; 

5 (B) in a hospital emergency room, when 

6 the substance is in short supply; 

7 (C) for a certified opioid treatment pro8 gram; or 

9 (D) in other situations as the Attorney 

10 General may reasonably determine; 

11 (4) the term ‘‘prescriber’’ means a dispenser 

12 who prescribes a controlled substance, or the agent 

13 of such a dispenser; and 

14 (5) the term ‘‘schedule II, III, or IV controlled 

15 substance’’ means a controlled substance that is list16 ed on schedule II, schedule III, or schedule IV of 

17 section 202(c) of the Controlled Substances Act (21 

18 U.S.C. 812(c)). 

19 (b) PLANNING AND IMPLEMENTATION GRANTS.— 

20 (1) IN GENERAL.—The Attorney General, in co21 ordination with the Secretary of Health and Human 

22 Services and the Director of the Office of National 

23 Drug Control Policy, may award grants to States, 

24 and combinations thereof, to prepare a comprehenVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00064 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
65 

•S 2839 IS

1 sive plan for and implement an integrated opioid 

2 abuse response initiative. 

3 (2) PURPOSES.—A State receiving a grant 

4 under this section shall establish a comprehensive 

5 response to opioid abuse, which shall include— 

6 (A) prevention and education efforts 

7 around heroin and opioid use, treatment, and 

8 recovery; 

9 (B) a comprehensive prescription drug 

10 monitoring program to track dispensing of 

11 schedule II, III, or IV controlled substances, 

12 which shall include— 

13 (i) data sharing with other States by 

14 statute, regulation, or interstate agree15 ment; 

16 (ii) educating physicians, residents, 

17 medical students, and other prescribers of 

18 Schedule II, III, or IV controlled sub19 stances on the prescription drug moni20 toring program of the State; 

21 (C) developing, implementing, or expand22 ing the prescription drug and opioid addiction 

23 treatment program of the State by— 

24 (i) expanding programs for medication 

25 assisted treatment of prescription drug and 


emcdonald on DSK67QTVN1PROD with BILLS
66 

•S 2839 IS

1 opioid addiction, including training for 

2 treatment and recovery support providers; 

3 (ii) developing, implementing, or ex4 panding programs for behavioral health 

5 therapy for individuals who are in treat6 ment for prescription drug and opioid ad7 diction, including contingency manage8 ment, cognitive behavioral therapy, and 

9 motivational enhancements; or 

10 (iii) developing, implementing, or ex11 panding programs to screen individuals 

12 who are in treatment for prescription drug 

13 and opioid addiction for hepatitis C and 

14 HIV, and provide treatment for those indi15 viduals if clinically appropriate; and 

16 (D) developing, implementing, and expand17 ing programs to prevent overdose death of pre18 scription medications and opioids. 

19 (3) PLANNING GRANT APPLICATIONS.— 

20 (A) APPLICATION.— 

21 (i) IN GENERAL.—A State desiring a 

22 planning grant under this section to pre23 pare a comprehensive plan for an inte24 grated opioid abuse response initiative 

25 shall submit to the Attorney General an 


emcdonald on DSK67QTVN1PROD with BILLS
67 

•S 2839 IS

1 application in such form, and containing 

2 such information, as the Attorney General 

3 may prescribe by regulation or guidelines. 

4 (ii) REQUIREMENTS.—An application 

5 for a planning grant under this section 

6 shall, at a minimum, include— 

7 (I) a budget and a budget jus8 tification for the activities to be car9 ried out using the grant; 

10 (II) a description of the activities 

11 proposed to be carried out using the 

12 grant, including a schedule for com13 pletion of such activities; 

14 (III) outcome measures that will 

15 be used to measure the effectiveness 

16 of the programs and initiatives to ad17 dress opioids; and 

18 (IV) a description of the per19 sonnel necessary to complete such ac20 tivities. 

21 (B) PERIOD; NONRENEWABILITY.—A plan22 ning grant under this section shall be for a pe23 riod of 1 year. A State may not receive more 

24 than 1 planning grant under this section. 


emcdonald on DSK67QTVN1PROD with BILLS
68 

•S 2839 IS

1 (C) AMOUNT.—A planning grant under 

2 this section may not exceed $100,000, except 

3 that the Attorney General may, for good cause, 

4 approve a grant in a higher amount. 

5 (D) STRATEGIC PLAN AND PROGRAM IM6 PLEMENTATION PLAN.—A State receiving a 

7 planning grant under this section shall develop 

8 a strategic plan and a program implementation 

9 plan. 

10 (4) IMPLEMENTATION GRANTS.— 

11 (A) APPLICATION.—A State desiring an 

12 implementation grant under this section to im13 plement a comprehensive strategy for address14 ing opioid abuse shall submit to the Attorney 

15 General an application in such form, and con16 taining such information, as the Attorney Gen17 eral may prescribe by regulation or guidelines. 

18 (B) USE OF FUNDS.—A State that receives 

19 an implementation grant under this section 

20 shall use the grant for the cost of carrying out 

21 an integrated opioid abuse response program in 

22 accordance with this section, including for tech23 nical assistance, training, and administrative 

24 expenses. 


emcdonald on DSK67QTVN1PROD with BILLS
69 

•S 2839 IS

1 (C) REQUIREMENTS.—An integrated 

2 opioid abuse response program carried out 

3 using an implementation grant under this sec4 tion shall— 

5 (i) ensure that each prescriber of a 

6 schedule II, III, or IV controlled substance 

7 in the State— 

8 (I) registers with the prescription 

9 drug monitoring program of the 

10 State; and 

11 (II) consults the prescription 

12 drug monitoring program database of 

13 the State before prescribing a sched14 ule II, III, or IV controlled substance; 

15 (ii) ensure that each dispenser of a 

16 schedule II, III, or IV controlled substance 

17 in the State— 

18 (I) registers with the prescription 

19 drug monitoring program of the 

20 State; 

21 (II) consults the prescription 

22 drug monitoring program database of 

23 the State before dispensing a schedule 

24 II, III, or IV controlled substance; 

25 and 


emcdonald on DSK67QTVN1PROD with BILLS
70 

•S 2839 IS

1 (III) reports to the prescription 

2 drug monitoring program of the 

3 State, at a minimum, each instance in 

4 which a schedule II, III, or IV con5 trolled substance is dispensed, with 

6 limited exceptions, as defined by the 

7 State, which shall indicate the pre8 scriber by name and National Pro9 vider Identifier; 

10 (iii) require that, not fewer than 4 

11 times each year, the State agency or agen12 cies that administer the prescription drug 

13 monitoring program of the State prepare 

14 and provide to each prescriber of a sched15 ule II, III, or IV controlled substance an 

16 informational report that shows how the 

17 prescribing patterns of the prescriber com18 pare to prescribing practices of the peers 

19 of the prescriber and expected norms; 

20 (iv) if informational reports provided 

21 to a prescriber under clause (iii) indicate 

22 that the prescriber is repeatedly falling 

23 outside of expected norms, direct the pre24 scriber to educational resources on appro25 priate prescribing of controlled substances; 


emcdonald on DSK67QTVN1PROD with BILLS
71 

•S 2839 IS

1 (v) ensure that the prescriber licens2 ing board of the State receives a report de3 scribing any prescribers that repeatedly 

4 fall outside of expected norms, as described 

5 in clause (iii); 

6 (vi) require consultation with the Sin7 gle State Authority for Substance Abuse; 

8 and 

9 (vii) establish requirements for how 

10 data will be collected and analyzed to de11 termine the effectiveness of the program. 

12 (D) PERIOD.—An implementation grant 

13 under this section shall be for a period of 2 

14 years. 

15 (E) AMOUNT.—The amount of an imple16 mentation grant under this section may not ex17 ceed $5,000,000 except that the Attorney Gen18 eral may, for good cause, approve a grant in a 

19 higher amount. 

20 (5) PRIORITY CONSIDERATIONS.—In awarding 

21 planning and implementation grants under this sec22 tion, the Attorney General shall give priority to a 

23 State that— 

24 (A) provides civil liability protection for 

25 first responders, health professionals, and famVerDate Sep 11 2014 01:48 Sep 19, 2014 Jkt 039200 PO 00000 Frm 00071 Fmt 6652 Sfmt 6201 E:\BILLS\S2839.IS S2839

emcdonald on DSK67QTVN1PROD with BILLS
72 

•S 2839 IS

1 ily members administering naloxone to counter2 act opioid overdoses by— 

3 (i) enacting legislation that provides 

4 such civil liability protection; or 

5 (ii) providing a certification by the at6 torney general of the State that the attor7 ney general has— 

8 (I) reviewed any applicable civil 

9 liability protection law to determine 

10 the applicability of the law with re11 spect to first responders, health care 

12 professionals, family members, and 

13 other individuals who may administer 

14 naloxone to individuals reasonably be15 lieved to be suffering from opioid 

16 overdose; and 

17 (II) concluded that the law de18 scribed in subclause (I) provides ade19 quate civil liability protection applica20 ble to such persons; 

21 (B) have in effect legislation or implement 

22 a policy under which the State shall not termi23 nate, but may suspend, enrollment under the 

24 State plan for medical assistance under title 

25 XIX of the Social Security Act (42 U.S.C. 1396 


emcdonald on DSK67QTVN1PROD with BILLS
73 

•S 2839 IS

1 et seq.) for an individual who is incarcerated for 

2 a period of fewer than 2 years; 

3 (C) have a process for enrollment in serv4 ices and benefits necessary by criminal justice 

5 agencies to initiate or continue treatment in the 

6 community, under which an individual who is 

7 incarcerated may, while incarcerated, enroll in 

8 services and benefits that are necessary for the 

9 individual to continue treatment upon release 

10 from incarceration; 

11 (D) ensures the capability of data sharing 

12 with other States, such as by making data 

13 available to a prescription monitoring hub; 

14 (E) ensures that data recorded in the pre15 scription drug monitoring program database of 

16 the State is available within 24 hours, to the 

17 extent possible; and 

18 (F) ensures that the prescription drug 

19 monitoring program of the State notifies pre20 scribers and dispensers of schedule II, III, or 

21 IV controlled substances when overuse or mis22 use of such controlled substances by patients is 

23 suspected. 


emcdonald on DSK67QTVN1PROD with BILLS
74 

•S 2839 IS

1 (c) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $15,000,000 for each of fiscal years 2016 through 2020. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS